InsidersTradesSigma
삼익제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 삼익제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼익제약 has published 5 insider filings. Market capitalisation: €44.7bn. The latest transaction was filed on 25 June 2026 (Other). Among the most active insiders: 권영이. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
€76,464
1 ops.
Buy Volume
€89,675
1 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,973 of 26,270 companies
33.7
score / 100
Value21
Quality46
FCF yld-3.5%
Earn yld-2.0%
EV/EBITDA28.6x
ROE-1.2%
Gross mgn71%
Net mgn-1.3%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 June 2026
Declarations5 total
5 of 5 declarations
About 삼익제약
Samik Pharmaceutical is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and production of drugs and pharmaceutical products.